Mealey's (April 29, 2022, 2:08 PM EDT) -- TRENTON, N.J. — A request by Celgene Corp. for dismissal of allegations that it violated state and federal antitrust laws was denied April 27 by a federal judge in New Jersey, who instead found that the dispute over supracompetitive pricing for the brand drugs “Thalomid” and “Revlimid” should proceed....